0.4EUR
620.36 MEUR
5.70 BEUR
1.22 B
About TERUMO CORP.
Sector
Industry
CEO
Hikaru Samejima
Website
Headquarters
Tokyo
Employees (FY)
30.21 K
Founded
1921
ISIN
JP3546800008
FIGI
BBG000C4GHY5
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange TERUMO CORP. stocks are traded under the ticker TUO.
TERUMO CORP. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
TUO earnings for the last quarter are 0.12 EUR per share, whereas the estimation was 0.10 EUR resulting in a 16.88% surprise. The estimated earnings for the next quarter are 0.13 EUR per share. See more details about TERUMO CORP. earnings.
TERUMO CORP. revenue for the last quarter amounts to 1.45 B EUR despite the estimated figure of 1.39 B EUR. In the next quarter revenue is expected to reach 1.46 B EUR.
Yes, you can track TERUMO CORP. financials in yearly and quarterly reports right on TradingView.
TUO net income for the last quarter is 191.37 M EUR, while the quarter before that showed 174.36 M EUR of net income which accounts for 9.76% change. Track more TERUMO CORP. financial stats to get the full picture.
TERUMO CORP. dividend yield was 1.12% in 2022, and payout ratio reached 33.61%. The year before the numbers were 0.91% and 28.95% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, TUO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TERUMO CORP. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 30.21 K employees. See our rating of the largest employees — is TERUMO CORP. on this list?
We've gathered analysts' opinions on TERUMO CORP. future price: according to them, TUO price has a max estimate of 21.42 EUR and a min estimate of 14.78 EUR. Read a more detailed TERUMO CORP. forecast: see what analysts think of TERUMO CORP. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TERUMO CORP. EBITDA is 1.29 B EUR, and current EBITDA margin is 22.87%. See more stats in TERUMO CORP. financial statements.